Fbxo6 confers drug ‐sensitization to cisplatin via inhibiting the activation of Chk1 in non‐small cell lung cancer
This article is protected by copyright. All rights reserved.
Source: FEBS Letters - Category: Biochemistry Authors: Lin Cai,
Jingduo Li,
Jing Zhao,
Yingxue Guo,
Menghua Xie,
Xiupeng Zhang,
Liang Wang,
Hua Tian,
Ailin Li,
Qingchang Li,
Yuan Miao Tags: Research Letter Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Lung Cancer | Men | Non-Small Cell Lung Cancer | Study